Barclays Bank PLC (the “Issuer”) announced today that, in
connection with its previously announced cash tender offers (each,
an “Offer”) to purchase any and all of its outstanding
exchange-traded notes (the “Notes” or the “ETNs”) of
five separate series (each, a “Series”) and the solicitation
of consents (each, a “Consent Solicitation”) from holders of
the Notes (the “Noteholders”) to amend certain provisions of
the Notes with respect to each Series, it has amended the Purchase
Price per Note applicable to certain Series.
Each Offer and Consent Solicitation is subject to the conditions
and restrictions set out in the Initial Statement, as supplemented
by Supplement No. 8 dated September 10, 2024 (as so supplemented,
and as it may be further supplemented or amended from time to time,
the “Statement”). The “Initial Statement” is
the Offer to Purchase and Consent Solicitation Statement dated
December 7, 2023, as supplemented by Supplement No. 1 dated March
7, 2024, Supplement No. 2 dated March 20, 2024, Supplement No. 3
dated April 4, 2024, Supplement No. 4 dated May 20, 2024,
Supplement No. 5 dated June 5, 2024, Supplement No. 6 dated July
16, 2024 and Supplement No. 7 dated July 31, 2024. Capitalized
terms used and not otherwise defined in this announcement have the
meanings given in the Statement.
Except as otherwise set forth below, the terms and conditions of
the Offers and Consent Solicitations as set forth in the Initial
Statement will continue to apply.
Purchase Price Amendments
For each Series listed in the table below, the Purchase Price
per Note has been amended from the value specified in the Initial
Statement. The specified Purchase Price per Note for each Series
listed below reflects a premium to the Closing Indicative Note
Value of that Series on September 10, 2024. The Purchase Price may
be lower than the trading price of the Notes of that Series on the
Expiration Date. The Expiration Date for each Series is September
25, 2024 and has not changed from the date specified in the Initial
Statement.
Title of Note
Bloomberg Ticker
CUSIP / ISIN
Purchase Price per
Note*
Closing Indicative Note Value
on September 10, 2024
iPath® CBOE S&P 500 BuyWrite IndexSM
ETN
BWVTF
06739F135 / GB00B1WL1590
$115.00
$108.77
iPath® Bloomberg Platinum Subindex Total
ReturnSM ETN
PGMFF
06739H255 / US06739H2554
$22.00
$18.59
* The Purchase Price for each Series is a set dollar
amount and may be lower than the Closing Indicative Note Value of
that Series on the Expiration Date.
If a Noteholder has already validly tendered and not withdrawn
its Notes of a Series pursuant to an Offer set forth in the Initial
Statement, such Noteholder is not required to take any further
action with respect to such Notes and such tender constitutes a
valid tender for purposes of the relevant Offer, as amended hereby.
Any amendment to the Purchase Price per Note set forth above will
be applicable to such Notes. The Purchase Price is payable on
October 2, 2024, unless the relevant Offer is further extended or
early terminated by the Issuer.
Because the Closing Indicative Note Value for each Series is
calculated based on the applicable Closing Index Level, if the
applicable Closing Index Level has increased as of the Expiration
Date, the Purchase Price of that Series may be significantly less
than the Closing Indicative Note Value on the Expiration Date. In
addition, the Notes of any Series may trade at a substantial
premium to or discount from the applicable Closing Indicative Note
Value. Accordingly, the Purchase Price for any Series may be lower
than the trading price of the Notes of that Series on the
Expiration Date.
Subject to applicable law, the Offer and Consent Solicitation
for each Series is being made independently of the Offer and
Consent Solicitation for each other Series, and the Issuer reserves
the right, subject to applicable law, to withdraw or terminate the
Offer and Consent Solicitation for any Series if any of the
conditions described in the Statement have not been satisfied or
waived without also withdrawing or terminating any other Offer or
Consent Solicitation. In addition, the Issuer reserves the right,
subject to applicable law, to extend or amend the Offer and Consent
Solicitation for any Series at any time and for any reason without
also extending or amending any other Offer or Consent
Solicitation.
For Further Information
A complete description of the terms and conditions of the Offers
is set out in the Statement. Copies of the Statement are available
at http://ipathetn.barclays/static/tenderoffers.app. Further
details about the transaction can be obtained from:
The Dealer Manager Barclays Capital Inc. 745 Seventh
Avenue New York, New York 10019, United States Telephone: +1
212-528-7990 Attn: Barclays ETN Desk Email:
etndesk@barclays.com
The Tender Agent The Bank of New York Mellon 160 Queen
Victoria Street London EC4V 4LA United Kingdom Attn: Debt
Restructuring Services Telephone: +44 1202 689644 Email:
debtrestructuring@bnymellon.com
DISCLAIMER
This announcement must be read in conjunction with the
Statement. No offer or invitation to acquire or exchange any
securities is being made pursuant to this announcement. This
announcement and the Statement contain important information, which
must be read carefully before any decision is made with respect to
the Offers and Consent Solicitations. If any Noteholder is in any
doubt as to the action it should take, it is recommended to seek
its own legal, tax and financial advice, including as to any tax
consequences, from its stockbroker, bank manager, lawyer,
accountant or other independent financial adviser. Any individual
or company whose Notes are held on its behalf by a broker, dealer,
bank, custodian, trust company or other nominee must contact such
entity if it wishes to participate in an Offer and Consent
Solicitation. None of the Issuer, the Dealer Manager or the Tender
Agent (or any person who controls, or is a director, officer,
employee or agent of such persons, or any affiliate of such
persons) makes any recommendation as to whether Noteholders should
participate in any Offer and Consent Solicitation.
General
Neither this announcement, the Statement nor the electronic
transmission thereof constitutes an offer to buy or the
solicitation of an offer to sell Notes (and tenders of Notes for
purchase pursuant to the Offers will not be accepted from
Noteholders) in any circumstances in which such Offer or
solicitation is unlawful. In those jurisdictions where the Notes,
blue sky or other laws require the Offers to be made by a licensed
broker or dealer and the Dealer Manager or any of its affiliates is
such a licensed broker or dealer in any such jurisdiction, the
Offers shall be deemed to be made by such Dealer Manager or such
affiliate, as the case may be, on behalf of the Issuer in such
jurisdiction. None of the Issuer, the Dealer Manager or the Tender
Agent (or any director, officer, employee, agent or affiliate of,
any such person) makes any recommendation as to whether Noteholders
should tender Notes in the Offers or Consent Solicitations. In
addition, each Noteholder participating in an Offer will be deemed
to give certain representations in respect of the other
jurisdictions referred to below and generally as set out in the
Statement under the section entitled “Procedures for Participating
in the Offer.” Any tender of Notes for purchase pursuant to an
Offer from a Noteholder that is unable to make these
representations will not be accepted.
About Barclays
Barclays is a British universal bank. We are diversified by
business, by different types of customers and clients, and by
geography. Our businesses include consumer banking and payments
operations around the world, as well as a full-service corporate
and investment bank. For further information about Barclays, please
visit our website www.barclays.com.
Selected Risk Considerations
An investment in the ETNs described herein involves risks.
Selected risks are summarized here, but we urge you to read the
more detailed explanation of risks described under “Risk Factors”
in the applicable prospectus supplement and pricing supplement.
You May Lose Some or All of Your Principal: The ETNs are exposed
to any change in the level of the underlying index (the
“index”) between the inception date and the applicable
valuation date. Additionally, if the level of the index is
insufficient to offset the negative effect of the investor fee and
other applicable costs, you will lose some or all of your
investment at maturity or upon redemption, even if the level of
such index has increased or decreased, as the case may be. The ETNs
are riskier than ordinary unsecured debt securities and have no
principal protection.
Credit of Barclays Bank PLC: The ETNs are unsecured debt
obligations of Barclays Bank PLC and are not, either directly or
indirectly, an obligation of or guaranteed by any third party. Any
payment to be made on the ETNs, including any payment at maturity
or upon redemption, depends on the ability of Barclays Bank PLC to
satisfy its obligations as they come due. As a result, the actual
and perceived creditworthiness of Barclays Bank PLC will affect the
market value, if any, of the ETNs prior to maturity or redemption.
In addition, if Barclays Bank PLC were to default on its
obligations, you may not receive any amounts owed to you under the
terms of the ETNs.
Market and Volatility Risk: The market value of the ETNs may be
influenced by many unpredictable factors and may fluctuate between
the date you purchase them and the maturity date or redemption
date. You may also sustain a significant loss if you sell your ETNs
in the secondary market. Factors that may influence the market
value of the ETNs include prevailing market prices of the commodity
markets, the U.S. stock markets or the U.S. Treasury market, the
index components included in the underlying index, and prevailing
market prices of options on such index or any other financial
instruments related to such index; and supply and demand for the
ETNs, including economic, financial, political, regulatory,
geographical or judicial events that affect the level of such index
or other financial instruments related to such index.
Concentration Risk: Because the ETNs are linked to an index
composed of futures contracts on a single commodity or in only one
commodity sector, the ETNs are less diversified than other funds.
The ETNs can therefore experience greater volatility than other
funds or investments.
A Trading Market for the ETNs May Not Develop: The ETNs are not
listed on any securities exchange. A trading market for the ETNs
may not develop and the liquidity of the ETNs may be limited.
No Interest Payments from the ETNs: You may not receive any
interest payments on the ETNs.
Uncertain Tax Treatment: Significant aspects of the tax
treatment of the ETNs are uncertain. You should consult your own
tax advisor about your own tax situation.
The ETNs may be sold throughout the day through certain
brokerage accounts. Commissions may apply and there are tax
consequences in the event of sale, redemption or maturity of ETNs.
Sales in the secondary market may result in significant
losses.
© 2024 Barclays Bank PLC. All rights reserved. iPath, iPath ETNs
and the iPath logo are registered trademarks of Barclays Bank PLC.
All other trademarks, servicemarks or registered trademarks are the
property, and used with the permission, of their respective
owners.
NOT FDIC INSURED · NO BANK GUARANTEE · MAY
LOSE VALUE
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240910556075/en/
Press Contact: Ann Thielke +1 212 526 1472
Ann.Thielke@barclays.com
Barclays (NYSE:BCS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Barclays (NYSE:BCS)
Historical Stock Chart
From Dec 2023 to Dec 2024